{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:21:34Z","timestamp":1793366494492,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2023SF59"],"award-info":[{"award-number":["2023SF59"]}]},{"name":"National High Level Hospital Clinical Research Fundin","award":["2022CR19"],"award-info":[{"award-number":["2022CR19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-024-03449-6","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:55:30Z","timestamp":1731632130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular classification and adjuvant treatment in endometrioid endometrial cancer with microcystic elongated and fragmented (MELF) invasion pattern"],"prefix":"10.1186","volume":"24","author":[{"given":"Peng","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-7552","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"issue":"1","key":"3449_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10333","key":"3449_CR2","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer Lancet. 2022;399(10333):1412\u201328.","journal-title":"Endometrial cancer Lancet"},{"issue":"3","key":"3449_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4274\/MMJ.galenos.2022.40336","volume":"37","author":"O Okcu","year":"2022","unstructured":"Okcu O, Askan G, Sen B, et al. Prognositc significance of Microcystic Elongated and Fragmanted (MELF) Myometrial Invasion Pattern: a retrospective Study. Medeni Med J. 2022;37(3):212\u20139.","journal-title":"Medeni Med J"},{"issue":"3","key":"3449_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ygyno.2022.06.027","volume":"166","author":"A van den Heerik","year":"2022","unstructured":"van den Heerik A, Aiyer KTS, Stelloo E, et al. Microcystic elongated and fragmented (MELF) pattern of invasion: molecular features and prognostic significance in the PORTEC-1 and \u2013\u20092 trials. Gynecol Oncol. 2022;166(3):530\u20137.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"3449_CR5","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1111\/jog.15335","volume":"48","author":"X Qi","year":"2022","unstructured":"Qi X, Zhu L, Zhang B. Clinicopathologic association and prognostic impact of microcystic, elongated and fragmented pattern invasion, combined with tumor budding in endometrioid endometrial cancer. J Obstet Gynaecol Res. 2022;48(9):2431\u201341.","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"3449_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","volume":"33","author":"A Oaknin","year":"2022","unstructured":"Oaknin A, Bosse TJ, Creutzberg CL, et al. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(9):860\u201377.","journal-title":"Ann Oncol"},{"issue":"7447","key":"3449_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, Schultz N, Cherniack AD, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373.","journal-title":"Nature"},{"key":"3449_CR8","doi-asserted-by":"crossref","unstructured":"Le\u00f3n-Castillo A, de Boer SM, Powell ME, et al. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. J Clin Oncol. 2020;38(29):3388-97.","DOI":"10.1200\/JCO.20.00549"},{"key":"3449_CR9","doi-asserted-by":"crossref","unstructured":"D\u2019Oria O, Giannini A, Besharat AR et al. Management of Endometrial Cancer: Molecular Identikit and tailored Therapeutic Approach. Clin Exp Obstet Gynecol. 2023;50(10):210.","DOI":"10.31083\/j.ceog5010210"},{"key":"3449_CR10","unstructured":"Editorial Board WCoT. WHO classification of Tumours Female Genital Tumours. Volume 4, 5th ed. International Agency for Research on Cancer; 2020."},{"key":"3449_CR11","doi-asserted-by":"crossref","unstructured":"He D, Wang H, Dong Y, et al. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women. Gynecol Oncol. 2020;159(1):36-42.","DOI":"10.1016\/j.ygyno.2020.07.102"},{"issue":"4","key":"3449_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","volume":"22","author":"SK Murray","year":"2003","unstructured":"Murray SK, Young RH, Scully RE. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Int J Gynecol Pathol. 2003;22(4):324\u201333.","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"3449_CR13","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.55730\/1300-0144.5497","volume":"52","author":"SD Alt\u0131nda\u011f","year":"2022","unstructured":"Alt\u0131nda\u011f SD, Yi\u011fit S, \u015een S. Is microcystic, elongated, and fragmented pattern of myometrial invasion in endometrioid endometrial carcinoma associated with survival?. Turk J Med Sci. 2022;52(5):1569\u201379.","journal-title":"Turk J Med Sci"},{"issue":"5","key":"3449_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/ajcp\/aqab036","volume":"156","author":"KM Rabe","year":"2021","unstructured":"Rabe KM, Klein ME, Ghatak S, et al. Sentinel Nodal Metastasis Detection in Endometrial Carcinoma with Microcystic, Elongated, and fragmented (MELF) pattern by Cytokeratin Immunostaining. Am J Clin Pathol. 2021;156(5):846\u201352.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"3449_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/path.5034","volume":"244","author":"J McAlpine","year":"2018","unstructured":"McAlpine J, Leon-Castillo A, Bosse T. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol. 2018;244(5):538\u201349.","journal-title":"J Pathol"},{"issue":"3","key":"3449_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/PGP.0000000000000980","volume":"43","author":"B Ju","year":"2024","unstructured":"Ju B, Wu J, Sun L, et al. Molecular classification of Endometrial Endometrioid Carcinoma with Microcystic Elongated and fragmented Pattern. Int J Gynecol Pathol. 2024;43(3):233\u201341.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"3449_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/PAS.0000000000000754","volume":"41","author":"AS Joehlin-Price","year":"2017","unstructured":"Joehlin-Price AS, McHugh KE, Stephens JA, et al. The Microcystic, Elongated, and fragmented (MELF) pattern of Invasion: a single Institution Report of 464 consecutive FIGO Grade 1 endometrial endometrioid Adenocarcinomas. Am J Surg Pathol. 2017;41(1):49\u201355.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3449_CR18","first-page":"139","volume":"30","author":"N Ozgul","year":"2020","unstructured":"Ozgul N, Oz Atalay F, Boyraz G, et al. Clinical significance of the MELF Pattern Myometrial Invasion in Low Grade Endometrioid Type Endometrial Carcinoma. Uluslararas\u0131 Hematoloji-Onkoloji Dergisi. 2020;30(3):139\u201347.","journal-title":"Uluslararas\u0131 Hematoloji-Onkoloji Dergisi"},{"key":"3449_CR19","doi-asserted-by":"crossref","unstructured":"Arciuolo D, Travaglino A, Santoro A et al. L1CAM expression in Microcystic, Elongated, and fragmented (MELF) glands predicts Lymph Node involvement in endometrial Carcinoma. Cancers (Basel). 2022;14(15):3635.","DOI":"10.3390\/cancers14153635"},{"key":"3449_CR20","doi-asserted-by":"publisher","first-page":"153699","DOI":"10.1016\/j.prp.2021.153699","volume":"229","author":"S Tahara","year":"2022","unstructured":"Tahara S, Kohara M, Sato K, et al. Strong expression of PD-L1 in invasive front of MELF pattern in endometrioid carcinoma. Pathol Res Pract. 2022;229:153699.","journal-title":"Pathol Res Pract"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03449-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T01:03:25Z","timestamp":1731632605000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03449-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3449"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03449-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"4 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institute Review Board of Peking University First Hospital (2022Y330). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"607"}}